141 related articles for article (PubMed ID: 7679662)
21. Anti-class II antibodies, but not cytotoxic T-lymphocyte antigen 4-immunoglobulin hybrid molecules, prevent rejection of major histocompatibility complex class II-negative myeloma in T-cell receptor-transgenic mice.
Dembic Z; Hofgaard PO; Omholt H; Bogen B
Scand J Immunol; 2004; 60(1-2):143-52. PubMed ID: 15238083
[TBL] [Abstract][Full Text] [Related]
22. HIV-1 envelope protein is expressed on the surface of infected cells before its processing and presentation to class II-restricted T lymphocytes.
Callahan KM; Rowell JF; Soloski MJ; Machamer CE; Siliciano RF
J Immunol; 1993 Sep; 151(6):2928-42. PubMed ID: 8376762
[TBL] [Abstract][Full Text] [Related]
23. Human CD14 is an efficient target for recombinant immunoglobulin vaccine constructs that deliver T cell epitopes.
Tunheim G; Schjetne KW; Fredriksen AB; Sandlie I; Bogen B
J Leukoc Biol; 2005 Mar; 77(3):303-10. PubMed ID: 15576418
[TBL] [Abstract][Full Text] [Related]
24. Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen-MHC class I presentation pathway.
Rock KL; Clark K
J Immunol; 1996 May; 156(10):3721-6. PubMed ID: 8621907
[TBL] [Abstract][Full Text] [Related]
25. Development of an I-Ag7-expressing antigen-presenting cell line: intrinsic molecular defect in compact I-Ag7 dimer generation.
Nabavieh A; Chou H; Volokhov I; Lee JE; Purdy LE; Elliott JF; Singh B; Madrenas J
J Autoimmun; 1998 Feb; 11(1):63-71. PubMed ID: 9480724
[TBL] [Abstract][Full Text] [Related]
26. Mycobacterium leprae 65hsp antigen expressed from a retroviral vector in a macrophage cell line is presented to T cells in association with MHC class II in addition to MHC class I.
Silva CL; Palacios A; Colston MJ; Lowrie DB
Microb Pathog; 1992 Jan; 12(1):27-38. PubMed ID: 1560752
[TBL] [Abstract][Full Text] [Related]
27. Recognition of mycobacterial HSP65 in association with HLA-DR4 is not sufficient for autoreactivity.
Mustafa AS
Nutrition; 1995; 11(5 Suppl):661-4. PubMed ID: 8748246
[TBL] [Abstract][Full Text] [Related]
28. Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis.
Schaible UE; Winau F; Sieling PA; Fischer K; Collins HL; Hagens K; Modlin RL; Brinkmann V; Kaufmann SH
Nat Med; 2003 Aug; 9(8):1039-46. PubMed ID: 12872166
[TBL] [Abstract][Full Text] [Related]
29. Differential requirements for the processing and presentation of soluble and particulate bacterial antigens by macrophages.
Ziegler HK; Orlin CA; Cluff CW
Eur J Immunol; 1987 Sep; 17(9):1287-96. PubMed ID: 3115792
[TBL] [Abstract][Full Text] [Related]
30. Inhibitory effects of thymus-independent type 2 antigens on MHC class II-restricted antigen presentation: comparative analysis of carbohydrate structures and the antigen presenting cell.
González-Fernández M; Carrasco-Marín E; Alvarez-Domínguez C; Outschoorn IM; Leyva-Cobián F
Cell Immunol; 1997 Feb; 176(1):1-13. PubMed ID: 9070312
[TBL] [Abstract][Full Text] [Related]
31. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD
J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040
[TBL] [Abstract][Full Text] [Related]
32. A role for the Hsp90 molecular chaperone family in antigen presentation to T lymphocytes via major histocompatibility complex class II molecules.
Rajagopal D; Bal V; Mayor S; George A; Rath S
Eur J Immunol; 2006 Apr; 36(4):828-41. PubMed ID: 16552710
[TBL] [Abstract][Full Text] [Related]
33. Heat shock proteins implicated in antigen processing and presentation.
De Nagel DC; Pierce SK
Semin Immunol; 1991 Jan; 3(1):65-71. PubMed ID: 1716503
[TBL] [Abstract][Full Text] [Related]
34. Major histocompatibility class II molecules prevent destructive processing of exogenous peptides at the cell surface of macrophages for presentation to CD4 T cells.
von Delwig A; Musson JA; Gray J; McKie N; Robinson JH
Immunology; 2005 Feb; 114(2):194-203. PubMed ID: 15667564
[TBL] [Abstract][Full Text] [Related]
35. Antigens targeted to the Leishmania phagolysosome are processed for CD4+ T cell recognition.
Kaye PM; Coburn C; McCrossan M; Beverley SM
Eur J Immunol; 1993 Sep; 23(9):2311-9. PubMed ID: 8103748
[TBL] [Abstract][Full Text] [Related]
36. [Antigen processing and antigen presentation by accessory cells of the immune system].
Langner J
Allerg Immunol (Leipz); 1985; 31(3):131-56. PubMed ID: 2416210
[TBL] [Abstract][Full Text] [Related]
37. The processing and presentation of Listeria monocytogenes antigens by macrophages.
Ziegler HK
Clin Invest Med; 1984; 7(4):269-72. PubMed ID: 6442650
[TBL] [Abstract][Full Text] [Related]
38. Mechanisms of major histocompatibility complex class II-restricted processing and presentation of the V antigen of Yersinia pestis.
Shim HK; Musson JA; Harper HM; McNeill HV; Walker N; Flick-Smith H; von Delwig A; Williamson ED; Robinson JH
Immunology; 2006 Nov; 119(3):385-92. PubMed ID: 16919002
[TBL] [Abstract][Full Text] [Related]
39. Schwann cells are able to present exogenous mycobacterial hsp70 to antigen-specific T lymphocytes.
Ford AL; Britton WJ; Armati PJ
J Neuroimmunol; 1993 Mar; 43(1-2):151-9. PubMed ID: 7681446
[TBL] [Abstract][Full Text] [Related]
40. New generation vaccines: does antibody play a directional role in antigen-processing?
Watson JD; Backstrom BT; Doherty TM
Am J Trop Med Hyg; 1991 Apr; 44(4 Pt 2):28-33. PubMed ID: 1710425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
